BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 19359914)

  • 1. Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma.
    Magnotti LJ; Schroeppel TJ; Clement LP; Swanson JM; Bee TK; Maish GO; Minard G; Zarzaur BL; Fischer PE; Fabian TC; Croce MA
    J Trauma; 2009 Apr; 66(4):1052-8; discussion 1058-9. PubMed ID: 19359914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia.
    Mueller EW; Croce MA; Boucher BA; Hanes SD; Wood GC; Swanson JM; Chennault SK; Fabian TC
    J Trauma; 2007 Dec; 63(6):1329-37; discussion 1337. PubMed ID: 18212657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for relapse of ventilator-associated pneumonia in trauma patients.
    Rangel EL; Butler KL; Johannigman JA; Tsuei BJ; Solomkin JS
    J Trauma; 2009 Jul; 67(1):91-5; discussion 95-6. PubMed ID: 19590315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal threshold for diagnosis of ventilator-associated pneumonia using bronchoalveolar lavage.
    Miller PR; Meredith JW; Chang MC
    J Trauma; 2003 Aug; 55(2):263-7; discussion 267-8. PubMed ID: 12913635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
    Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit?
    Wahl WL; Franklin GA; Brandt MM; Sturm L; Ahrns KS; Hemmila MR; Arbabi S
    J Trauma; 2003 Apr; 54(4):633-8; discussion 638-9. PubMed ID: 12707523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of sputum gram stain for the determination of appropriate antibiotic therapy in ventilator-associated pneumonia.
    Raghavendran K; Wang J; Belber C; Misra SR; Brunton K; Berbary E; Burke MS; Haas CE
    J Trauma; 2007 Jun; 62(6):1377-82; discussion 1382-3. PubMed ID: 17563652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.
    McMillian WD; Bednarik JL; Aloi JJ; Ahern JW; Crookes BA
    J Trauma; 2010 Oct; 69(4):861-5. PubMed ID: 20938272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia.
    Heyland DK; Dodek P; Muscedere J; Day A; Cook D;
    Crit Care Med; 2008 Mar; 36(3):737-44. PubMed ID: 18091545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
    Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of preliminary bacterial colony counts from bronchoalveolar lavage in critically ill trauma patients.
    Mueller EW; Wood GC; Kelley MS; Boucher BA; Fabian TC; Croce MA
    Am Surg; 2003 Sep; 69(9):749-55; discusiion 755-6. PubMed ID: 14509321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779].
    Damas P; Garweg C; Monchi M; Nys M; Canivet JL; Ledoux D; Preiser JC
    Crit Care; 2006; 10(2):R52. PubMed ID: 16569261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of empiric antibiotic administration for suspected pneumonia on subsequent opportunistic pulmonary infections.
    Koontz CS; Chang MC; Meredith JW
    Am Surg; 2000 Dec; 66(12):1110-4; discussion 1114-5. PubMed ID: 11149581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of broncho-alveolar lavage fluid Gram's stain in the diagnosis of ventilator-associated pneumonia: a prospective study.
    Goldberg AE; Malhotra AK; Riaz OJ; Aboutanos MB; Duane TM; Borchers CT; Martin N; Ivatury RR
    J Trauma; 2008 Oct; 65(4):871-6; discussion 876-8. PubMed ID: 18849805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of preliminary bronchoalveolar lavage results in suspected ventilator-associated pneumonia.
    Swanson JM; Wood GC; Croce MA; Mueller EW; Boucher BA; Fabian TC
    J Trauma; 2008 Dec; 65(6):1271-7. PubMed ID: 19077612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Nicolau DP; Shore E; Palter M; Pepe J; Kuti JL
    J Crit Care; 2010 Mar; 25(1):69-77. PubMed ID: 19427167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causative pathogen dictates optimal duration of antimicrobial therapy for ventilator-associated pneumonia in trauma patients.
    Magnotti LJ; Croce MA; Zarzaur BL; Swanson JM; Wood GC; Weinberg JA; Fabian TC
    J Am Coll Surg; 2011 Apr; 212(4):476-84; discussion 484-6. PubMed ID: 21463773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.